节点文献

曼月乐治疗原发性痛经的临床观察

The clinical observation of Mirena in the treatment of primary dysmenorrheal

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 马蔷董武白枫王雅娟

【Author】 MA Qiang DONG Wu BAI Feng WANG Yajuan Department of Obstetrics and Gynaecology,the People’s Hospital of Liaoning Province,Shenyang 110016,China

【机构】 辽宁省人民医院妇产科

【摘要】 目的探讨放置左炔诺酮宫内节育器(LNG-IUS,曼月乐)对原发性痛经患者的治疗效果。方法回顾性研究2008年2月~2011年1月我院妇科门诊原发性痛经患者50例,分为A组21例放置曼月乐作为研究组,B组29例给予口服避孕药治疗作为对照组,观察50例患者放置曼月乐及口服避孕药后连续随访3个月的痛经程度。结果治疗30 d、60 d、90 d后,两组患者的子宫体积比较,差异无统计学意义(P>0.05)。治疗30 d、60 d、90 d后,两组的月经量和VAS评分比较,差异有统计学意义(P<0.05)。结论曼月乐是治疗原发性痛经一种较为有效且安全的方法。

【Abstract】 Objective To investigate the effect of Levonorgestrel-releasing intrauterine device(LNG-IUD,Mirena) placed in patients with primary dysmenorrhea.Methods All of 50 cases of gynecological patients were retrospectively analyzed form February 2008 to January 2011 in our hospital.Group A(21 patients) were treated with Mirena as test group,Group B(29 patients)were treated with oral contraceptive as control group.50 patients were followed up in 1,2,3 months after treatment.Results The uterine volume of 30 days,60 days and 90 days after the treatment was no significant difference between Group A and Group B(P > 0.05).However,the menstrual quantity and the dysmenorrheal score of 30 days,60 days and 90 days after treatment had significant difference between two groups(P < 0.05).Conclusion Mirena is an effective and safe therapy for primary dysmenorrhea.

  • 【文献出处】 中国现代医生 ,China Modern Doctor , 编辑部邮箱 ,2012年26期
  • 【分类号】R711.5
  • 【被引频次】25
  • 【下载频次】121
节点文献中: